In view of the well-known phenomenon of trophoblast immune privilege, trophoblast stem cells (TSCs) might be expected to be immune privileged, which could be of interest for cell or gene therapies. Yet in the ectopic sites tested so far, TSC transplants fail to show noticeable immune privilege and seem to lack physiological support. However, we show here that after portal venous injection, green fluorescent protein (GFP)-labeled TSCs survive for several months in the livers of allogeneic female but not male mice. Gonadectomy experiments revealed that this survival does not require the presence of ovarian hormones but does require the absence of testicular factors. By contrast, GFP-labeled allogeneic embryonic stem cells (ESCs) are reliably rejected; however, these same ESCs survive when mixed with unlabeled TSCs. The protective effect does not require immunological compatibility between ESCs and TSCs. Tumors were not observed in animals with either successfully engrafted TSCs or coinjected ESCs. We conclude that in a suitable hormonal context and location, ectopic TSCs can exhibit and confer immune privilege. These findings suggest applications in cell and gene therapy as well as a new model for studying trophoblast immunology and physiology.
INTRODUCTION
fetus. Based on this notion, we surmised that a partially immune-privileged site other than the uterus might also The isolation of mouse trophoblast stem cells (TSCs) allow TSCs to survive and to exert a protective action (30) and the in vitro differentiation of human embryonic upon other nearby cells, enabling the latter to survive in stem cells (ESCs) into trophoblast cells (32) seemed to locations where they normally could not. Furthermore, open fascinating prospects for using the phenomenon of because trophoblast cells normally occur only in fetrophoblast immune privilege (18, 25, 31) in heterologous males, we also wondered whether a female hormonal transplantation and cell therapy (29) . However, attempts environment is one of the physiological requirements for to transplant wild-type TSCs or their in vitro-differentiectopic TSC survival. Here, we show that (i) the liver ated derivatives have not been promising. When injected provides a physiological and immunological environsubcutaneously into nonpregnant females, syngeneic TSCs ment conducive for prolonged TSC survival, which aldifferentiated within 5-10 days into giant trophoblast lowed us to further demonstrate (ii) a surprising lack of cells that rapidly degenerated thereafter (10) . Following dependence of TSC survival on systemically provided injection into the tail veins of nonpregnant females, alloovarian hormones, (iii) a striking susceptibility of transgeneic TSCs and trophoblast cells were cleared from planted TSCs to testicular factors, and (iv) a strong imhost lungs by natural killer cells within a day (10) . TSCs munoprotective effect of injected TSCs on coinjected subcutaneously injected at high dosage into male nude ESCs. Together, these findings provide a framework for mice formed giant trophoblast and spongiotrophoblast using transplanted TSCs and their derivatives in cell and cells that were resorbed within 2 weeks (20) . Thus, in gene therapy and as a model to study trophoblast immuthe ectopic sites tested so far, TSCs/trophoblast cell nology and physiology. transplants fail.
Research in sheep has shown that the uterus becomes
MATERIALS AND METHODS moderately immune privileged under the influence of
Cell Lines progesterone (17); hence, the previous failure to achieve TSC engraftment may indicate that synergistic interacWe used three ESC lines: a strain 129 line expressing GFP under control of the Hprt promoter (19) ; a C57Bl/ tion of trophoblastic and uterine immune mechanisms is required for the survival of the trophoblast and hence the 6 line purchased from the ATCC (SCRC-1002); and a 770 EPPLE-FARMER ET AL.
CBA line (21). The C57Bl/6 and CBA ES cells were deferens as well as prominent ovarian and testicular blood vessels. labeled with GFP as described further below. The ESCs were maintained on mitomycin-treated primary mouse embryo fibroblasts in the presence of 1,000 U/ml LIF Histology and Microscopy (ESGRO). We also utilized two TSC lines: an outbred
Cryosections. The liver pieces were fixed in 4% (ICR) GFP-transgenic line (30) and a hybrid (C57Bl/ paraformaldehyde (24 h, 4°C), soaked in 30% sucrose 6xBalb/c F1) line that was derived in our laboratory as (48-72 h, 4°C), and then placed in OTC and frozen at described (30) , except that we doubled the amount of −180°C for at least 24 h. Serial 10-µm sections were cut FGF and added TGFb (11) during derivation and mainfrom calculated locations within each liver piece with a tenance. In addition, the "rat ESC-like cells" (line B10)
Tissue Tek II cryotome (Miles, Inc.). The sections were were cultured as described previously (13) .
viewed with an Olympus IX 71 microscope outfitted with a wide GFP fluorescence filter (U-N31054).
Labeling of Cells
Hematoxylin/Eosin (H/E) Staining. In order to preVirus suspensions were produced using the GFPserve the integrity of the cryosectioned tissue throughout expressing lentiviral vector pFUGW (22) and titered staining, a thin coating of 1% celloidin was applied for after serial dilution by counting the number of GFP-5 min and allowed to dry, followed by standard H/E positive 293T cells. The ESCs or TSCs were seeded at staining. All sections that are compared with each other moderate density in 60-mm plates and incubated overwere photographed at the same original microscopic night. Two hours before transduction, the medium was magnification and are presented at the same final magnichanged, and transductions were carried out for 24 h at fication. a multiplicity of infection of ϳ1 in the presence of 8 µg/ml Polybrene (Sigma). The transduced cells where Definition of Transplant Survival and Survival Index passaged at low density, and after 7-14 days the fluoresThe liver of each animal was cut into four quarters. cent colonies were picked, pooled, and further expanded Initially, one quarter was cryosectioned, resulting in for the injections. about 50 cryosections separated by approximately even distances. If at least one of those cryosections showed Preparation of Cells for Injection an unambiguous patch of intact fluorescent cells, the Through trypsinization and pipetting, the cells were transplant was scored as a survival and the remaining thoroughly disaggregated into a mixture of predomiquarters were not studied. If, however, the first quarter nantly single cells and some small aggregates (poorly did not reveal transplant survival, a further quarter was disaggregated samples caused instantaneous death). The analyzed and so on. As a semiquantitative assessment of cells were counted with a hemocytometer, aliquoted into the survival, we determined a "survival index" as the portions of ϳ1 million cells per 0.2 ml of PBS, and percentage of slides containing one or more unambigukept on ice until injection; under these conditions they ous patches of fluorescent cells. survived for at least 4 h (by trypan blue exclusion), a time that was never exceeded. Immediately before injec-RT-PCR tion, the cells were resuspended by gently flicking the Total RNA was isolated with the TRIZOL (Intube.
vitrogen) procedure. After treatment with DNAse I, 2 µg of RNA were reverse-transcribed with random hexamers Surgeries using the first-strand cDNA synthesis Superscript II from Invitrogen; control reactions excluded reverse tranAll animal experiments were approved by the University Laboratory Animal Care Commission. The mice scriptase. Aliquots of the cDNA samples were subjected to PCR, using an annealing temperature of 60°C. The were purchased from the Jackson Laboratory and maintained under specified pathogen-free conditions with primers used and the resulting product sizes (in bp) are: Oct4 (gagggatggcatactgtggac, ggtgtaccccaaggtgatcc; 272); free access to food and water in a 0600 to 1800 h light cycle. The surgeries were performed under isofluorene Nanog (tatcccagcatccattgcag, gtcctccccgaagttatggag; 252); Gata6 (gccgggagcaccagtaca, gtgacagttggcacaggacag; 419); anesthesia. For portal vein injections, the abdominal cavity was opened, cells were slowly infused using a 30-Eomesodermin (cggcaaagcggacaataac, gttgtcccggaagcct ttg; 361); placental lactogen (ctgcttccatccatactccaga, gac gauge syringe, and bleeding was prevented by briefly applying digital pressure. Ovarectomies and orchidectoaactcggcacctcaaga; 410); Errbeta (ctccagcatctccaggaa gag, cacttggggaccagatgagc; 464); Hprt (cagtcccagcgtcgt mies were performed after exteriorizing the gonads through small incisions and ligating the oviduct and vas gattag, atccagcaggtcagcaaagaac; 229); Cdx2 (ctctcggag agcccaagtgtg, gcagtccctaggaagccaagtga; 162); FAS ligand and the downregulation of TSC markers (Cdx2, Eomes, Errbeta) upon removal of FGF4 (Fig. 1B) . In addition, (aaccccagtacaccctctgaaa, ggttccatatgtgtcttcccattc, 108).
the giant trophoblast differentiation marker placental RESULTS lactogen was found both in the presence and absence of FGF, indicating background differentiation [comp. ref.
Green Fluorescent Protein (GFP)-Labeled Allogeneic (30)]. TSCs Survive Portal Vein (PV) Injection
In our cell line comparisons, we also included a rat blastocyst-derived cell line of uncertain identity that we In preliminary experiments, we first tested a ranhave previously found to be immune privileged after PV domly chosen, outbred TSC line derived from GFPinjection (13); these rat cells had first been presumed to transgenic ICR mice (30) for its ability to survive PV be ESC-like but this identity was later put into question injection into Balb/c mice (MHC haplotype H2k-d).
(5). We now find, in agreement with Buehr et al. (5), When inspected ϳ1 month after injection, the livers of that our rat cells lack the key ESC marker Oct4 but exthe TSC-injected mice all showed large patches of fluopress the trophectoderm/trophoblast lineage markers rescent cells (Table 1 , group 1). Use of outbred cells, Cdx2, Eomesodermin, and Placental Lactogen (Fig. 1B) . however, complicates the analysis of strain combinaAlso, the TSCs and the trophectoderm-like rat cell cultions. Therefore, in order to repeat these experiments tures, but not the mouse ESCs, express an mRNA enwith genetically defined TSCs, we derived a new TSC coding FAS ligand (Fig. 1B) , although we did not deterline (F1 TSCs) from C57Bl/6[H2k-b]xBalb/c F1 mice mine whether FAS ligand was present on undifferentiated and labeled it with GFP by lentiviral transduction. Based or only differentiated cells. FAS ligand is not a lineage on well-known specific features of mouse TSCs (30) marker, but is of interest as an immunomodulatory moland in direct comparison with ICR TSCs and other emecule that we have previously implicated in the allogebryo stem cell lines, the identity of the new TSC line neic survival of the rat cells (13) . was verified through its morphology (Fig. 1A) , molecuHaving ascertained their identity, we injected the lar signature (Cdx2
newly derived, genetically defined mouse TSCs into female Balb/c mice. Again, the injected TSCs survived in all cases (Table 1 , group 2), appearing either as tight previously observed lack of tumor formation after synof castrated males provided a perfect environment for the TSCs) ( Table 1 , cp. groups 2, 6, and 8; Fig. 3B ). geneic TSC injection into other sites (10) and suggests that when ectopic TSCs survive in vivo, they undergo Each of these two results argues that (i) contrary to what might be expected, female hormones are not required differentiation.
and (ii) male hormones are toxic for the survival of PV-TSC Survival Requires a Nonmale injected TSCs.
Hormonal Environment
Duration of TSC Survival We next determined the significance of host gender.
The experiments described so far were all terminated TSCs that were PV injected into females always sur-1 month after injection. In order to determine the duravived in the host liver (Table 1 , groups 1-4); by contion of TSC survival, we killed the injected mice at diftrast, we did not observe a significant survival of TSCs ferent time points and assessed the transplant survival injected into male hosts, regardless of syngeneic or not with a semiquantitative approach. The results showed (Table 1 , groups 5 and 6). This result was not unexthat there was no appreciable decrease until 3 months, pected because the natural environment of the conceptus but at 4 months they had disappeared in four out of five suggests a requirement for female hormones, but foranimals, with only a trace left in the fifth (Fig. 3A ). mally it was also possible that rejection of the TSCs In summary, PV-injected TSCs survive for 3 months was caused by male hormones. In order to distinguish with little if any proliferation, regardless of their immubetween these two possibilities, we performed the expernological compatibility but dependent on a nonmale horiments with gonadectomized females and males. The remonal context. sults showed that, unexpectedly, ovarectomy had no ef-GFP-Labeled Allogeneic ESCs Are Rejected After fect (i.e., the livers of ovarectomized females provided PV Injection a perfect environment for the TSCs) (Table 1, cp. groups 2 and 7; Fig. 3B ). In striking contrast, castration comNext, we injected GFP-labeled ESCs into Balb/c mice. In experiments involving allogeneic ESCs from pletely abolished the gender difference (i.e., the livers three different genetic backgrounds (129, C57Bl/6, not survive for any duration in previously tested ectopic locations, can survive for 3 months in the liver. Thus, in CBA), out of 13 transplants none survived until 4 weeks after injection (Table 1 , groups 9, 10, and 11; Fig. 3C ).
our model, the liver seems to play a uterus-like role both physiologically and immunologically, the latter role beBy contrast, syngeneic ESCs (C57Bl/6 → C57Bl/6) always survived and tended to form tumors (Table 1, ing in line with the well-known fact that the liver environment can provide a certain degree of immune privigroup 12). As expected, these tumors exhibited differentiation into cell types of all three germ layers (histology lege (3). On the other hand, immune-privileged features of the trophoblast lineage (18, 25, 31 ) are also important results not shown), attesting to the pluripotency of the cells. We did, however, observe modest patches of fluocontributors to survival of the GFP-labeled TSCs because the liver is incapable of protecting GFP-labeled rescent cells until 2 weeks after injection, in line with the comparatively low immunogenicity of mouse ESCs ESCs [(12), present study]. Note in this respect that although rejection of PV-injected ESCs from different ge-(2). At the same time (2 weeks after injection), we observed a massive macrophage and lymphocyte infiltranetic backgrounds was highly reproducible in our setup, this has not been a universal observation (23); factors tion of the ESC transplant, indicating that an immune reaction led to the disappearance of the ESCs (Fig. 2Cc) .
causing variability appear to include the immunogenicity of GFP, cell dosage, recipient age/strain/health, and In summary, GFP-labeled allogeneic ESCs never survived longer than two weeks after PV injection.
the time point studied (1, 4, 15, 27, 28) . Within the accuracy of our semiquantitative method,
PV-Injected Allogeneic TSCs Rescue the Survival the number of surviving TSC-derived cells was unof Coinjected GFP-Labeled ESCs
changed during the first 3 months after transplantation, but clearly declined dramatically in the fourth month. Having demonstrated that GFP-labeled TSCs but not ESCs survived allogeneic PV injection, we tested whether
We cannot exclude that this decline was due to a lateonset immune reaction, but a nonimmunological, trans-GFP-labeled ESCs could be rescued by coinjecting them with nonlabeled TSCs. We first mixed C57Bl/6xBalb/c plant-intrinsic mechanism appears to explain the observed time pattern more easily. Indeed, because the F1 TSCs with C57Bl/6 ESCs. All livers from mice with mixed injections showed large patches of fluorescent transplanted TSCs did not seem to proliferate, they must have differentiated rapidly into trophoblast cells [comp. cells (Fig. 2B, Table 1, group 13; Fig. 3C ), indicating that the TSCs had rescued the ESCs. We then tested ref. (10)], a cell type whose natural life span is rather short (that the TSC transplants nevertheless lasted longer whether a haplotype overlap between the ESCs and TSCs was required for the rescue. To this end, we inthan a normal pregnancy may reflect a reserve ensuring that trophoblast life span does not limit pregnancy). The jected CBA (H2k-k) ESCs together with C57Bl/6(H2k-b)xBalb/c(H2k-d) TSCs. The results showed that the assumption that TSC differentiation lead to transplant rejection is less plausible in view of the known immune CBA ESCs survived in all injected mice (Table 1, group 14) to the same degree as observed before with the privilege of the differentiated trophoblast (18, 25, 31) ; it is also hard to imagine that a dramatic immune response C57Bl/6 ESCs (Fig. 3C) . Overall, in experiments involving allogeneic ESCs from two different genetic starts only 3 months after TSC transplantation. Future experiments will discriminate immunological from nonbackgrounds, nine out of nine ESC transplants survived when coinjected with TSCs. No teratomas were obimmunological mechanisms of TSC transplant demise by comparing long-term (>3 months) transplant survival served in the mixed injections, but we did notice that compared to the standard 1-month time point (and unin syngeneic, allogeneic, and immune-suppressed allogeneic hosts. like our observations with the TSC transplants), the survival index of the coinjected, GFP-labeled C57Bl/6
The second finding of this report is that the survival of the transplanted TSCs is not due to their requiring ESCs had increased further by 2 months after injection (Fig. 3C) . Finally, because hematopoietic chimerism has ovarian hormones, but does require absence of products of the male gonads. Such long survival of trophoblast been observed after PV injection of the rat "ESC-like cells" (13) and after (nonhepatic) injection of allogeneic cells in the absence of ovarian hormones has not previously been observed. Future work will determine mouse ESCs (2), we also determined whether GFPexpressing cells were present in the blood of ESC/TSCwhether the opposite treatment, namely addition of a pregnant hormonal context, exerts any effect in our injected mice. No fluorescent cells were seen at the time points studied (2 and 4 weeks after injection).
model. Also, we are not aware of any report that testicular factors have a detrimental influence on trophoblast DISCUSSION survival in vivo. However, it has been reported that in the presence of low-density lipoproteins, supraphysioThe primary finding of this report is that allogeneic TSCs, which normally reside inside the uterus and did logical doses of testosterone can exert a toxic effect on freshly isolated term human trophoblast cells (33) ; furintrahepatic TSC survival (which exceeds normal trophoblast life span more than threefold) makes these cells thermore, male hormones have shown proinflammatory effects (14) that may play a role in abortion (7) . Thus, particularly interesting as conditioning reagents, especially because the hepatic environment is known to faour model provides a starting point for systematically assessing the hormonal and other physiological requirecilitate tolerance induction (3). Finally, we note that the present results confirm the ments for trophoblast cells in vivo.
The third finding of this report is the ability of PVsuspicion, caused by the findings of Buehr et al. (5), that rat blastocyst-derived "ESC-like cells" previously injected TSCs to protect GFP-labeled ESCs that are allogeneic with respect to the host. This suggests that the shown by us to survive allogeneic PV injection (13) are not bona fide ESCs but exhibit trophoblastic features. ESCs benefit as bystander cells from the well-known ability of trophoblast cells to exert various forms of local However, these rat cells are not TSCs either, because they can give rise to blood chimerism (13) , have differimmune suppression (18, 25, 31) . However, in view of the known tendency of trophoblast cells to fuse with ent growth factor requirements (5), and can form syngeneic tumors (unpublished). Nevertheless, their trophoeach other (24), we cannot exclude the possibility that the ESCs fused with the TSCs, and the fused cells mainblastic features raise the possibility that the rat "ESC-like cells" share with mouse TSCs some mechanisms of imtained the immune privilege of the TSCs. However, that possibility is made less likely when we consider the exmune privilege.
In conclusion, our results suggest that it is worthtremely high efficiency of the observed ESC rescue. It is important to note that the protected ESCs did not have while to explore a new "stem cell-based trophoblastic approach" to therapeutic cell transplantation. It will be to be of the same genetic background as the TSCs, which is in line with the largely nonspecific nature of at of interest to compare this approach with the Sertoli cellbased approach being explored by other laboratories least some of the mechanisms of local trophoblast immune suppression, and is of interest with respect to po- (8, 9, 16 fascinating subjects for future research.
Even without an ability to protect coinjected cells,
